Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Evolving strategies to address adverse transplant outcomes associated with T cell depletion. J Hematother Stem Cell Res 2000 Jun;9(3):327-37

Date

07/14/2000

Pubmed ID

10894354

DOI

10.1089/15258160050079434

Scopus ID

2-s2.0-0033945340 (requires institutional sign-in at Scopus site)   24 Citations

Abstract

Graft-versus-host disease (GVHD) is the major complication of allogeneic bone marrow transplantation (BMT). The most effective strategy to reduce GVHD has been T cell depletion (TCD) of the donor marrow graft. Although TCD has reduced both the incidence and severity of GVHD, it has been associated with an increased rate of graft rejection and an impairment in immune reconstitution after transplant. Relapse rates in selected hematologic malignancies have also been higher after TCD allogeneic BMT. Over the past several years, a number of clinical strategies have been developed in an effort to reduce adverse transplant outcomes associated with TCD. This review examines some of the strategies designed to promote alloengraftment, prevent relapse, and enhance immune reconstitution after TCD.

Author List

Drobyski WR

Author

William R. Drobyski MD Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Blood Component Removal
Bone Marrow Transplantation
Clinical Protocols
Graft vs Host Disease
Humans
Lymphocyte Depletion
T-Lymphocytes
Transplantation, Homologous
Treatment Outcome